October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Intralesional corticosteroids work better than topical ones for hair regrowth in alopecia areata.
September 2025 in “Acta Dermato Venereologica” Intralesional corticosteroids may be more effective than cryotherapy for hair regrowth in alopecia areata.
August 2025 in “Journal of Affective Disorders” This study found that gender-diverse individuals experienced higher depression and anxiety levels alongside lower cortisol concentrations, resembling profiles typical in trauma and pain-related conditions.
June 2025 in “Archives of Dermatological Research” May 2025 in “OSF Preprints (OSF Preprints)” Machine learning can help identify stress indicators in mothers and infants.
May 2025 in “Psychoneuroendocrinology” Discrimination during pregnancy affects newborn stress hormone levels.
July 2024 in “Nursing Research” This study highlights the use of hair and fingernail cortisol levels as retrospective indicators of chronic stress, particularly in minoritized populations facing social stressors that increase the risk of mental health issues.
February 2024 in “Psychoneuroendocrinology” This study found that among mother-infant pairs during the COVID-19 pandemic, lower maternal hair cortisol concentrations during pregnancy, combined with higher levels at six weeks postpartum, were associated with poorer infant developmental outcomes at six months.
February 2024 in “Psychoneuroendocrinology” This study observed that higher anxiety levels in pregnant individuals are negatively correlated with neonatal hair cortisol, suggesting that increased anxiety during pregnancy may affect fetal cortisol accumulation, which is important for fetal development and associated with birth outcomes and cognitive function.
February 2024 in “Psychoneuroendocrinology” In this study, researchers found that higher levels of general and pregnancy-related anxiety during gestation were negatively correlated with neonatal hair cortisol levels, suggesting that increased maternal anxiety may alter fetal cortisol exposure, which is important for fetal development.
November 2023 in “Deleted Journal” In this study, the researchers found no superiority of combining 308-nm excimer laser with intralesional corticosteroid over corticosteroid alone for treating frontal fibrosing alopecia, and reported side effects such as erythema and postinflammatory hyperpigmentation in both treatment groups.
September 2023 in “Journal of the American Academy of Dermatology” Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.
May 2023 in “Animal Reproduction Update” This article reviews the use of hair cortisol concentration as a biomarker to assess long-term stress in both animals and humans, but it reports no new experimental results.
Topical corticosteroids are effective for skin conditions but can have side effects.
March 2023 in “Journal of Pakistan Association of Dermatologists” This case study reports a good response and tolerability for a combination treatment involving high potency topical corticosteroid, minoxidil 2%, LED, and inosine pranobex in a child with alopecia areata.
January 2023 in “Research Square (Research Square)” This study suggests that measuring cortisol levels in hair may serve as a useful biomarker for assessing mood in individuals with bipolar disorder over recent months.
November 2022 in “Innovation in aging” This study reports that hair cortisol measurement in older Puerto Rican adults found a significant portion had non-detectable cortisol levels, especially among black participants, influencing exclusion rates in such populations.
February 2022 in “Cleveland Clinic Journal of Medicine” This case report observed hypertrichosis on the left forearm of an 80-year-old woman, possibly linked to her previous use of the topical steroid betamethasone butyrate propionate for dermatitis.
September 2021 in “Psychoneuroendocrinology” This study observed that female nurses experienced higher hair cortisol concentrations, indicating increased stress, during periods of the COVID-19 pandemic compared to the summer release period.
May 2021 in “Journal of the Endocrine Society” This case report highlights the importance of timely biochemical and radiographic evaluation of adrenal masses, as illustrated by a rapidly progressing aggressive adrenal cortical carcinoma.
June 2020 in “Journal of skin and stem cell” This case report describes a 19-year-old female with recurrent alopecia totalis who experienced complete remission after re-treatment with various therapies, emphasizing the importance of long-term follow-up in managing alopecia areata.
April 2020 in “Journal of the Endocrine Society” This study suggests that hair cortisol measurement could serve as an alternative diagnostic method for Cushing’s disease, showing acceptable concordance with urinary free cortisol despite differing evaluated periods.
February 2020 in “VSNU Open Access deal” This study established age-adjusted reference intervals for hair cortisol in children from birth to 18 years, finding higher cortisol levels in infants possibly linked to slower hair growth.
December 2019 in “Case Medical Research”
October 2019 in “International journal of research in dermatology” This case report describes two instances of hyper-pigmentation induced by prolonged misuse of Betnovate cream, where cessation and appropriate treatment led to significant improvement within 15 days.
January 2018 in “Belarusian State Pedagogical University repository (Belarusian State Pedagogical University)” This study observed that stress, as indicated by hair cortisol concentrations, may trigger onset of hair loss in alopecia areata, although the findings were not statistically significant.
September 2017 in “OhioLink ETD Center (Ohio Library and Information Network)” In this study, dementia caregivers showed lower hair cortisol levels than controls despite reporting higher perceived stress, providing weak support for the Perseverative Cognition Hypothesis and suggesting complex effects of caregiving stress.
April 2016 in “Journal of The American Academy of Dermatology” Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.
January 2013 in “Journal of dermatology” This letter to the editor raises the possibility of a new medical entity characterized by symptoms such as poikiloderma, hyperpigmentation, alopecia, malformed bones, lymphedema, and decreased cortisol, but provides no clinical results.
December 2011 in “InTech eBooks” This review discusses the potential role of systemic corticosteroids in the treatment of progressive vitiligo, but reports no new clinical results and suggests further research is needed.